ACT-IG Trademark

Trademark Overview


On Wednesday, September 25, 2019, a trademark application was filed for ACT-IG with the United States Patent and Trademark Office. The USPTO has given the ACT-IG trademark a serial number of 79277722. The federal status of this trademark filing is REGISTERED as of Tuesday, January 11, 2022. This trademark is owned by CHUGAI SEIYAKU KABUSHIKI KAISHA (ChugaiPharmaceutical Co., Ltd.). The ACT-IG trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Pharmaceutical preparations for human use, namely, pharmaceutical antibodies and their fragments and derivatives, cells and genes that produces antibodies, and fragments of antibodies and derivatives of antibodies, all for preventing or treating infectious and parasitic diseases, cancer, blood and blood-forming organs diseases and disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, and congenital malformations, deformations and chromosomal abnormalities, for medical and pharmaceutical use

Granting of licenses to others for the use of industrial property rights and copyright

Pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals
act-ig

General Information


Serial Number79277722
Word MarkACT-IG
Filing DateWednesday, September 25, 2019
Status700 - REGISTERED
Status DateTuesday, January 11, 2022
Registration Number6610076
Registration DateTuesday, January 11, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use, namely, pharmaceutical antibodies and their fragments and derivatives, cells and genes that produces antibodies, and fragments of antibodies and derivatives of antibodies, all for preventing or treating infectious and parasitic diseases, cancer, blood and blood-forming organs diseases and disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, and congenital malformations, deformations and chromosomal abnormalities, for medical and pharmaceutical use
Goods and ServicesGranting of licenses to others for the use of industrial property rights and copyright
Goods and ServicesPharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 7, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 7, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 7, 2020
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCHUGAI SEIYAKU KABUSHIKI KAISHA (ChugaiPharmaceutical Co., Ltd.)
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameCHUGAI SEIYAKU KABUSHIKI KAISHA (ChugaiPharmaceutical Co., Ltd.)
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameCHUGAI SEIYAKU KABUSHIKI KAISHA (ChugaiPharmaceutical Co., Ltd.)
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Monday, August 1, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, June 24, 2022GENERIC MADRID TRANSACTION SENT TO IB
Thursday, June 23, 2022GENERIC MADRID TRANSACTION CREATED
Monday, April 11, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 11, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, November 4, 2021NOTIFICATION PROCESSED BY IB
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 6, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 6, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, September 18, 2021EXPARTE APPEAL TERMINATED
Friday, September 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 17, 2021EXAMINER'S AMENDMENT ENTERED
Friday, September 17, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 17, 2021EXAMINERS AMENDMENT E-MAILED
Friday, September 17, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 3, 2021ASSIGNED TO EXAMINER
Saturday, July 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, July 7, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 7, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, June 23, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, April 8, 2021NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Thursday, April 8, 2021ACTION DENYING REQ FOR RECON E-MAILED
Thursday, April 8, 2021ACTION CONTINUING FINAL - COMPLETED
Friday, March 19, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, March 19, 2021EX PARTE APPEAL-INSTITUTED
Friday, March 19, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, March 19, 2021EXPARTE APPEAL RECEIVED AT TTAB
Saturday, September 26, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, September 26, 2020FINAL REFUSAL E-MAILED
Saturday, September 26, 2020FINAL REFUSAL WRITTEN
Wednesday, September 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 31, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 31, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 31, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, March 31, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 31, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 31, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, March 21, 2020REFUSAL PROCESSED BY IB
Thursday, March 5, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 5, 2020REFUSAL PROCESSED BY MPU
Wednesday, February 12, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 11, 2020NON-FINAL ACTION WRITTEN
Tuesday, February 11, 2020APPLICATION FILING RECEIPT MAILED
Friday, February 7, 2020ASSIGNED TO EXAMINER
Friday, February 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 6, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB